4.7 Article

Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial

Natalia McInnes et al.

Summary: The study aimed to evaluate the remission of type 2 diabetes after a short-term intervention using insulin glargine, sitagliptin/metformin, and lifestyle approaches. The results showed that although the primary outcome was not statistically significant, the intervention group had a lower risk of relapse and a higher number of participants remaining in remission in some supplementary analyses.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Remission of Type 2 Diabetes

Dylan MacKay et al.

CANADIAN JOURNAL OF DIABETES (2022)

Article Endocrinology & Metabolism

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes

Daniel R. Quast et al.

Summary: Both long-acting (liraglutide) and short-acting (lixisenatide) glucagon-like peptide-1 receptor agonists have similar effects on body weight, energy, and macronutrient intake. Both treatments are associated with improved exocrine pancreas function. Reductions in appetite and body weight as a result of treatment with short- or long-acting GLP-1 RAs are not driven by changes in gastric emptying or gastrointestinal side effects.

DIABETES OBESITY & METABOLISM (2021)

Article Endocrinology & Metabolism

Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin

Natalia McInnes et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial

Mathias Ried-Larsen et al.

DIABETES OBESITY & METABOLISM (2019)

Article Endocrinology & Metabolism

Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial

Natalia McInnes et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Article Primary Health Care

The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial

Wilma S. Leslie et al.

BMC FAMILY PRACTICE (2016)

Editorial Material Endocrinology & Metabolism

Introduction

Alice Y. Y. Cheng

CANADIAN JOURNAL OF DIABETES (2013)

Article Medicine, General & Internal

Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes

Edward W. Gregg et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Medicine, General & Internal

Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes

Geltrude Mingrone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial

John B. Dixon et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Health Care Sciences & Services

Validation of two generic patient-reported outcome measures in patients with type 2 diabetes

Louis S. Matza et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2007)

Article Multidisciplinary Sciences

Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome

James D. Johnson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Sport Sciences

International physical activity questionnaire:: 12-country reliability and validity

CL Craig et al.

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)